1. Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant.
- Author
-
Fournier, Pierre-Edouard, Colson, Philippe, Levasseur, Anthony, Devaux, Christian A., Gautret, Philippe, Bedotto, Marielle, Delerce, Jeremy, Brechard, Ludivine, Pinault, Lucile, Lagier, Jean-Christophe, Fenollar, Florence, and Raoult, Didier
- Subjects
- *
SARS-CoV-2 , *COVID-19 - Abstract
• The severe acute respiratory syndrome (SARS-CoV-2) Marseille-4 variant caused an epidemic that started in August and is still ongoing. • This variant harbours 13 hallmark mutations, including one in the spike receptor binding domain. • The variant predominated in Marseille from September 2020 and caused a re-infection in 11 patients. • Hypoxemia was more frequent than with clade 20A strains that circulated before May 2020. • The sudden appearance of Marseille-4 points towards an animal reservoir, possibly mink. In Marseille, France, following a first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in March–May 2020, a second epidemic phase occurred from June, involving 10 new variants. The Marseille-4 variant caused an epidemic that started in August and is still ongoing. The 1038 SARS-CoV-2 whole genome sequences obtained in our laboratory by next-generation sequencing with Illumina technology were analysed using Nextclade and nextstrain/ncov pipelines and IQ-TREE. A Marseille-4-specific qPCR assay was implemented. Demographic and clinical features were compared between patients with the Marseille-4 variant and those with earlier strains. Marseille-4 harbours 13 hallmark mutations. One leads to an S477N substitution in the receptor binding domain of the spike protein targeted by current vaccines. Using a specific qPCR, it was observed that Marseille-4 caused 12–100% of SARS-CoV-2 infections in Marseille from September 2020, being involved in 2106 diagnoses. This variant was more frequently associated with hypoxemia than were clade 20A strains before May 2020. It caused a re-infection in 11 patients diagnosed with different SARS-CoV-2 strains before June 2020, suggesting either short-term protective immunity or a lack of cross-immunity. Marseille-4 should be considered as a major SARS-CoV-2 variant. Its sudden appearance points towards an animal reservoir, possibly mink. The protective role of past exposure and current vaccines against this variant should be evaluated. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF